Purpose

Interventional study to use erector spinae plane block (ESPB) on diagnoses of posterior or lateral rib fractures, vertebral fractures, pancreatitis, pancreatic cancer, renal colic, and back pain for multimodal pain therapy to determine its assistance with pain relief as well as the patient's use of opiates after block completion

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Posterior/lateral rib or vertebral fractures - Pancreatitis or pancreatic cancer - Renal colic - Back pain

Exclusion Criteria

  • Unstable vitals - Infection or open wound over insertion site - Prior allergic reaction to local anesthetic - Pregnant females - Patients <18 years old - Altered mentation

Study Design

Phase
Early Phase 1
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Intervention Model Description
Single group open label assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Erector Spinae Plane Block (ESP) administration
Patients with the listed diagnoses will be offered and then consented for an ESPB under ultrasound guidance.
  • Drug: Bupivacaine Injection
    Bucivacaine will be administered intramuscularly according to package insert directions after first numbing the area with lidocaine subcutaneously
    Other names:
    • Bupivacaine Hydrochloride Injection

Recruiting Locations

University Hospital
San Antonio, Texas 78229
Contact:
Morgan Ritz, MD
972-757-2495
ritzm@uthscsa.edu

More Details

Status
Recruiting
Sponsor
The University of Texas Health Science Center at San Antonio

Study Contact

Morgan Ritz, MD
972-757-2495
ritzm@uthscsa.edu

Detailed Description

Patients with the listed diagnoses will be offered and then consented for an ESPB under ultrasound guidance. They will rate their pain before and 30 minutes after the procedure using the ordinal categorical data on a numeric pain scale. Total patient opiate use will be gathered up to 8 hours after block completion.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.